Ultrasound stimulation represents a rapidly evolving field that harnesses acoustic energy to non-invasively modulate neural circuitry. This approach offers exceptional spatial resolution and depth ...
NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
NEWTOWN, Pa., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation ...
- This demonstration of a miniature implantable stimulator used in humans could unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders - Approximately 30% of adults ...
NEWTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...
Unlike clinical-grade stimulators that require medical supervision or invasive procedures, Pulsetto is positioned within the ...
Dublin, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Global Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. Neuromodulation is gaining ...
On July 30, the FDA approved the first device of its kind — a vagal nerve stimulator for adults with moderate to severe ...
Helius Medical Technologies Inc (NASDAQ:HSDT) shares are trading higher after the Centers for Medicare & Medicaid Services assigned Healthcare Common Procedure Coding System (HCPCS) Level II codes ...